The U.S. FDA has approved Tandem’s t:slim G4 insulin pump. The t:slim G4 combines features of the t:slim Insulin Pump and Dexcom's G4 PLATINUM CGM System into a single device that is simple to use. The t:slim G4 insulin pump is the only pump that conveniently displays CGM graphs and trend information with current insulin delivery activity together on the home screen to help make informed treatment decisions. Orders for the t:slim G4 Insulin Pump can be placed now with shipments expected to begin in October 2015.
Category: Products & Tech
Insulet Corporation (Insulet or the Company) has initiated a lot-specific voluntary recall of 40,846 boxes (10 Pods per box) of the OmniPod (Pod)…
The U.S. Food and Drug Administration (FDA) has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System. With wireless Bluetooth technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver.
The penny-sized patch is embedded with more than one hundred tiny needles, each about the width and length of an eyelash. Those needles in turn are loaded with microscopic storage units containing insulin and glucose-sensing enzymes that trigger a release of insulin when blood sugar levels go past a certain level.
Todd Hobbs, the chief medical officer for North America at Novo Nordisk, knows diabetes from all angles: as a patient; as an endocrinologist (for ten years he ran a clinical practice focused on patients of all ages with diabetes); as an executive at a pharmaceutical company working to develop new treatments (he’s worked at Novo Nordisk since 2004); and as a parent (one of his six sons was diagnosed with type 1 at age five)
I came across a bottle of glucose control solution. It was expired, of course. When we were still in the hospital just after my son’s diagnosis, our diabetes educator had taught us how to use the solution to ensure the accuracy of a new batch of strips. We used it once or twice, and honestly, that’s the last time we used the stuff.
A yearlong clinical trial in more than a dozen countries reveals that once-a-week-Trulicity, used in conjunction with short acting insulin, not only improved blood sugar control for subjects with type 2 diabetes, but also curbed hypoglycemia compared to a standard treatment and reduced weight in trial subjects.
Only a tiny number of cases of diabetic ketoacidosis have been reported with SGLT2 inhibitor treatment, so this is unlikely to be a major issue for these drugs, which are very useful in controlling blood glucose in a number of ways.
Dexcom has partnered with recording artist and actor, Nick Jonas, who has Type 1 diabetes, to raise awareness of the benefits of continuous glucose monitoring (CGM) for people with diabetes. Jonas will share his personal story and views on living with diabetes and his use of Dexcom technology to help him monitor his glucose levels and manage his diabetes.
Abbott’s Freestyle Precision Neo is as slender a meter as you will find on the market, with a battery that will last for thousands and thousands of blood glucose checks. While the meter itself is inexpensive ($22-27 depending on retailer), one of several features of the Neo that is revolutionary is that the strips are priced low enough that Abbott tells customers they can “skip the co-pay.” A box of 50 strips is less than $25, as low as $19 from some retailers.